Raymond James & Associates’s FibroGen FGEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-2,090
| Closed | -$975K | – | 3807 |
|
|
2023
Q1 | $975K | Sell |
2,090
-29
| -1% | -$13.5K | ﹤0.01% | 2450 |
|
|
2022
Q4 | $849K | Buy |
2,119
+792
| +60% | +$317K | ﹤0.01% | 2526 |
|
|
2022
Q3 | $432K | Sell |
1,327
-56
| -4% | -$18.2K | ﹤0.01% | 2939 |
|
|
2022
Q2 | $365K | Buy |
1,383
+32
| +2% | +$8.45K | ﹤0.01% | 3088 |
|
|
2022
Q1 | $406K | Sell |
1,351
-68
| -5% | -$20.4K | ﹤0.01% | 3177 |
|
|
2021
Q4 | $500K | Sell |
1,419
-38
| -3% | -$13.4K | ﹤0.01% | 3074 |
|
|
2021
Q3 | $372K | Buy |
1,457
+3
| +0.2% | +$766 | ﹤0.01% | 3251 |
|
|
2021
Q2 | $968K | Buy |
+1,454
| New | +$968K | ﹤0.01% | 2600 |
|
|
2019
Q2 | – | Sell |
-620
| Closed | -$843K | – | 3547 |
|
|
2019
Q1 | $843K | Buy |
620
+161
| +35% | +$219K | ﹤0.01% | 2300 |
|
|
2018
Q4 | $531K | Sell |
459
-59
| -11% | -$68.3K | ﹤0.01% | 2514 |
|
|
2018
Q3 | $787K | Sell |
518
-9
| -2% | -$13.7K | ﹤0.01% | 2403 |
|
|
2018
Q2 | $825K | Buy |
527
+66
| +14% | +$103K | ﹤0.01% | 2341 |
|
|
2018
Q1 | $533K | Buy |
461
+27
| +6% | +$31.2K | ﹤0.01% | 2520 |
|
|
2017
Q4 | $514K | Sell |
434
-113
| -21% | -$134K | ﹤0.01% | 2509 |
|
|
2017
Q3 | $736K | Buy |
+547
| New | +$736K | ﹤0.01% | 2265 |
|